1281 related articles for article (PubMed ID: 2147946)
1. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
[TBL] [Abstract][Full Text] [Related]
2. A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.
Moretta A; Tambussi G; Bottino C; Tripodi G; Merli A; Ciccone E; Pantaleo G; Moretta L
J Exp Med; 1990 Mar; 171(3):695-714. PubMed ID: 2137855
[TBL] [Abstract][Full Text] [Related]
3. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
[TBL] [Abstract][Full Text] [Related]
4. Surface molecules involved in CD3-negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cells.
Moretta A; Ciccone E; Tambussi G; Bottino C; Viale O; Pende D; Santoni A; Mingari MC
Int J Cancer Suppl; 1989; 4():48-52. PubMed ID: 2478490
[TBL] [Abstract][Full Text] [Related]
5. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes.
Zambello R; Trentin L; Ciccone E; Bulian P; Agostini C; Moretta A; Moretta L; Semenzato G
Blood; 1993 May; 81(9):2381-5. PubMed ID: 8481518
[TBL] [Abstract][Full Text] [Related]
7. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.
Moretta A; Vitale M; Bottino C; Orengo AM; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Moretta L
J Exp Med; 1993 Aug; 178(2):597-604. PubMed ID: 8340759
[TBL] [Abstract][Full Text] [Related]
8. Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery.
Moretta A; Bottino C; Tripodi G; Vitale M; Pende D; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Millo R
Int J Cancer Suppl; 1992; 7():6-10. PubMed ID: 1428407
[TBL] [Abstract][Full Text] [Related]
9. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
[TBL] [Abstract][Full Text] [Related]
10. Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones.
Ferrini S; Prigione I; Miotti S; Ciccone E; Cantoni C; Chen Q; Colnaghi MI; Moretta L
Int J Cancer; 1991 May; 48(2):227-33. PubMed ID: 1826900
[TBL] [Abstract][Full Text] [Related]
11. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
Moretta A; Sivori S; Vitale M; Pende D; Morelli L; Augugliaro R; Bottino C; Moretta L
J Exp Med; 1995 Sep; 182(3):875-84. PubMed ID: 7650491
[TBL] [Abstract][Full Text] [Related]
12. Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans.
Moretta A; Ciccone E; Pantaleo G; Tambussi G; Bottino C; Melioli G; Mingari MC; Moretta L
Immunol Rev; 1989 Oct; 111():145-75. PubMed ID: 2697680
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans.
Ciccone E; Pende D; Viale O; Di Donato C; Tripodi G; Orengo AM; Guardiola J; Moretta A; Moretta L
J Exp Med; 1992 Mar; 175(3):709-18. PubMed ID: 1371301
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC
J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709
[TBL] [Abstract][Full Text] [Related]
15. In vitro expansion of CD3/TCR- human thymocyte populations that selectively lack CD3 delta gene expression: a phenotypic and functional analysis.
Poggi A; Biassoni R; Pella N; Paolieri F; Bellomo R; Bertolini A; Moretta L; Mingari MC
J Exp Med; 1990 Nov; 172(5):1409-18. PubMed ID: 2146363
[TBL] [Abstract][Full Text] [Related]
16. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
Poggi A; Pella N; Morelli L; Spada F; Revello V; Sivori S; Augugliaro R; Moretta L; Moretta A
Eur J Immunol; 1995 Feb; 25(2):369-76. PubMed ID: 7875198
[TBL] [Abstract][Full Text] [Related]
17. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
18. Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells.
Ciccone E; Pende D; Viale O; Tambussi G; Ferrini S; Biassoni R; Longo A; Guardiola J; Moretta A; Moretta L
J Exp Med; 1990 Jul; 172(1):47-52. PubMed ID: 1694227
[TBL] [Abstract][Full Text] [Related]
19. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.
Moretta A; Vitale M; Sivori S; Bottino C; Morelli L; Augugliaro R; Barbaresi M; Pende D; Ciccone E; Lopez-Botet M; Moretta L
J Exp Med; 1994 Aug; 180(2):545-55. PubMed ID: 8046333
[TBL] [Abstract][Full Text] [Related]
20. Analysis of natural killer (NK) cell subsets defined by the expression of two novel surface antigens (EB6 and GL183) in AIDS and AIDS-related conditions.
Cauda R; Goletti D; Lucia MB; Tumbarello M; Rumi C; Orengo AM; Moretta A
Clin Immunol Immunopathol; 1994 Mar; 70(3):198-205. PubMed ID: 8313656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
